tiprankstipranks
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
US Market
ANRO
Alto Neuroscience, Inc.
RESEARCH TOOLSreports
Want to see ANRO full AI Analyst Report?

Alto Neuroscience, Inc. (ANRO) Stock News & Sentiment

569 Followers
Alto Shifts Focus to ALTO-207 After ALTO-101 Data
Premium
Company Announcements
Alto Shifts Focus to ALTO-207 After ALTO-101 Data
1M ago
8K
ANRO
Pipeline Strength and Key Late-Stage Assets Drive Upside in Alto Neuroscience Despite ALTO-101 Setback
Premium
Ratings
Pipeline Strength and Key Late-Stage Assets Drive Upside in Alto Neuroscience Despite ALTO-101 Setback
1M ago
ANRO
Alto Neuroscience: Advancing Late-Stage CNS Pipeline and Strengthened Balance Sheet Support Favorable Risk-Reward Profile
Premium
Ratings
Alto Neuroscience: Advancing Late-Stage CNS Pipeline and Strengthened Balance Sheet Support Favorable Risk-Reward Profile
2M ago
ANRO
Alto Neuroscience: Advancing Precision-Psychiatry Pipeline and De-Risked Trials Support Buy Rating
Premium
Ratings
Alto Neuroscience: Advancing Precision-Psychiatry Pipeline and De-Risked Trials Support Buy Rating
2M ago
ANRO
Alto Neuroscience Secures $120 Million Private Placement Financing
Premium
Company Announcements
Alto Neuroscience Secures $120 Million Private Placement Financing
2M ago
8K
ANRO
Alto Neuroscience, Inc.: Promising Future with Strategic Advancements and Strong Financial Position
Premium
Ratings
Alto Neuroscience, Inc.: Promising Future with Strategic Advancements and Strong Financial Position
6M ago
ANRO
Promising Future for Alto Neuroscience: Buy Rating Backed by Strong Financials and Innovative Treatment Prospects
Premium
Ratings
Promising Future for Alto Neuroscience: Buy Rating Backed by Strong Financials and Innovative Treatment Prospects
6M ago
ANRO
More ANRO News >

ANRO News on the Web

Analysts’ Top Healthcare Picks: Boston Scientific (BSX), Alto Neuroscience, Inc. (ANRO)
TipRanks News
Neutral
Alto Neuroscience files to sell 6M shares of common stock for holders
TipRanks News
Bearish
Analysts Conflicted on These Healthcare Names: Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO)
TipRanks News
Neutral
Alto Neuroscience’s ALTO-101 miss doesn’t impact thesis, says H.C. Wainwright
TipRanks News
Neutral
Alto Neuroscience price target lowered to $21 from $22 at Wedbush
TipRanks News
Bearish
Morning Movers: Immunovant sinks after batoclimab trials miss goal
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Alto Neuroscience, Inc. (ANRO)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR), Alto Neuroscience, Inc. (ANRO) and Viridian Therapeutics (VRDN)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
ANRO
Sector Average
Media Buzz
This Week1 articles
Weekly Average5 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ANRO’s Media Buzz Sentiment?
1 articles about ANRO were published this week. In an average week, 5 articles are published.
    What is ANRO’s weekly average amount of articles?
    In an average week, 5 articles about ANRO are published.
      What is ANRO’s News Sentiment?
      50% of articles about ANRO were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week